Urinary miRNA in Endometrial Cancer Study

Royal Cornwall Hospitals Trust

Status: Completed

Conditions: Endometrial Cancer

Treatments: Diagnostic Test: Urinary miRNA

Study type: Observational

Funder types: Other

Identifiers

NCT03824613

2018.RCHT.97.

Details and patient eligibility

About

This study is a prospective feasibility study with the addition of a retrospective cohort study on the the expression of microRNA in urine in endometrial cancer patients.

Enrollment: 164 patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Confirmed diagnosis of endometrial cancer
• Age: 18 years or older

Exclusion criteria

• Prior or coexisting other malignancies
• Autoimmune disorders (other than diabetes mellitus)

Trial design

164 participants in 2 patient groups

Endometrial cancer patients

Treatment:

Diagnostic Test: Urinary miRNA

Control group

Description:

Patients without cancer

Treatment:

Diagnostic Test: Urinary miRNA